The road leading to the National Park Service headquarters and several attractions at Pictured Rocks National Lakeshore will close for two weeks in October. Sand Point Road, on the western end of the ...
A massive roadwork project is expected to hamper overnight traffic through Saturday, Sept. 26 on state highways in Bellmawr. Work on the Direct Connection brings lane and ramp closures to Route 42 ...
Chinese President Xi Jinping heads to the U.S. for his first state visit since the Obama administration. That May summit started "a U-turn in China-U.S. relations," said Zhou Bo, a senior fellow at ...
Scientists simulated what happens when the pipes and tunnels that divert rainwater fail. In one scenario, 30 percent of local residents couldn’t reach an E.R. By Alexander Nazaryan Culverts aren’t ...
Revolution Medicines recently made history with the approval of its RAS inhibitor Rasonque for advanced pancreatic cancer. But behind RevMed is an entire field of biotechs working to broaden the reach ...
OSCEOLA COUNTY, Fla. — A worker was rescued on Sept. 2 after becoming heavily entrapped in industrial machinery, according to Osceola County Professional Firefighters. The extrication operation lasted ...
The milestone comes as Hawaii regulators are considering a virtual power plant program that would compensate homeowners for the power their batteries send to the grid HONOLULU, Hawaii, Sept. 3, 2026 ...
The milestone comes as Hawaii regulators are considering a virtual power plant program that would compensate homeowners for the power their batteries send to the grid The milestone represents 1,800 ...
The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one ...
The FDA approved daraxonrasib, the first targeted therapy for metastatic pancreatic adenocarcinoma, citing a survival benefit vs chemotherapy. The FDA approved daraxonrasib (Rasonque; Revolution ...
The FDA has approved the first RAS-targeted therapy for metastatic pancreatic cancer, offering a new treatment option for patients with previously treated disease. Daraxonrasib (Rasonque, Revolution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results